Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1977-03-21
1979-04-17
Rush, Raymond V.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
260307R, 542414, 542421, 542426, 546209, C07D26348, A61K 3142
Patent
active
041501438
ABSTRACT:
Oxazoles which are substituted in the 2,4 or 5-position with an N-substituted-acylamino group have anti-allergic activity. Methods of making such compounds, pharmaceutical compositions containing the active compounds of the invention and methods of treating asthma utilizing such compounds are provided.
REFERENCES:
patent: 3152136 (1964-10-01), Harris et al.
patent: 3682945 (1972-08-01), Engelhart
Fromm et al, C.A. 23, 2177, (1929).
Beyer et al, C.A. 65, 8892g, (1966).
Clerin et al, Bull. de la Soc. Chim. Fr., 3127-41, (1973).
Neville Martin C.
Verge John P.
Ashbrook Charles W.
Buting Walter E.
Lilly Industries Limited
Rush Raymond V.
Smith Everet F.
LandOfFree
N-Substituted-acylamino-oxazoles as antiasthma agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-Substituted-acylamino-oxazoles as antiasthma agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-Substituted-acylamino-oxazoles as antiasthma agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1262252